J&J SIRIUS Trial First Test For Drug-Coated Stents In Longer Lesions

Johnson & Johnson's SIRIUS trial will be the first large-scale U.S. clinical study evaluating drug-coated stents for the reduction of restenosis in longer, more complicated lesions.